Investing News NetworkYour trusted source for investing success

Videos
Companies
Press Releases
Top Stocks
Top Resource Stocks
Top Tech Stocks
Top Life Science Stocks
Private Placements
Trending
Trending Articles

Leigh Goehring: Gold's "Massive Bull Market" Just Starting; Uranium and Copper Outlook

13 Canadian Crypto ETFs (Updated 2024)

10 Top Oil-producing Countries (Updated 2024)

When is the Starlink IPO Date and Can You Invest? (Updated 2024)

Could the Silver Price Really Hit $100 per Ounce? (Updated 2024)

How Would a New BRICS Currency Affect the US Dollar? (Updated 2024)

Uranium Stocks: 5 Biggest Companies in 2024

Top 4 Largest Lithium Reserves by Country (Updated 2024)

How Could Trump's US Election Win Affect the Gold Price?

Trending Press Releases

McDermitt PFS Demonstrates Multi-Decade Competitive Source of US Lithium Carbonate

OSISKO METALS EXPANDS LEADERSHIP TEAM AND ANNOUNCES C$100 MILLION BOUGHT DEAL FINANCING

Silver47 Drills 2.48m of 14.95 g/t Gold, 249.50 g/t Silver, 21.97% Zinc, 7.03% Lead, 0.42% Copper at Its Red Mountain Project, Alaska

First Helium Reviewing Potential Follow Up Targets to Leduc Anomaly Drill

SAGA Metals Announces Assay Results from North Wind Iron Ore Project

Sirona Biochem Announces Publication of Groundbreaking Study on TFC-1326 Compound in the Journal of Cosmetic Dermatology

More Press Releases
Trending Companies

Silver47 Exploration

AGA:CC

Purpose Bitcoin ETF

BTCC:CA

Syntheia

SYAI:CC

Jindalee Lithium

JLL:AU
More Companies
Trending Reports

2024 Gold Outlook Report

2024 Lithium Market Outlook

2024 AI Market Outlook Report

Silver Price Forecast - What Happened And Where Do We Go From Here?

More Outlook Reports
Resource
Resource
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Tech
Tech
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Life Science
Life Science
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Gold Price
Silver Price
Copper Price
Oil Price
Uranium
Artificial Intelligence
loader

BriaCell

TSX:BCT

Developing Personalized Off-The-Shelf Immunotherapy Treatments for Cancer Patients

Press Releases

BriaCell Partners with New York Cancer & Blood Specialists for Pivotal Phase 3 Study of Bria-IMT in Advanced Breast Cancer

BriaCell Initiates Pivotal Phase 3 Study of Bria-IMT in Advanced Metastatic Breast Cancer

BriaCell Reports Benchmark-Beating Patient Survival and Clinical Benefit in Advanced Metastatic Breast Cancer


Overview

BriaCell Therapeutics (NASDAQ:BCTX, BCTXW;TSX:BCT) is a clinical-phase biotechnology company developing innovative immunotherapies for treating cancer.

At the forefront of cancer treatments, immunotherapies boost the ability of the body's own cancer-fighting cells to destroy cancerous tumors. Immunotherapies also have low-toxicity, making it easier for patients to undergo treatment. Most importantly, they may offer better efficacy and less chance of recurrence for many cancer patients. A report released by Research and Markets says the global immuno-oncology market is expected to reach US$135 billion by 2024. BriaCell continues to uncover opportunities in this space with its innovative technologies.

Interactive Chart

×